Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV

Saved in:
Bibliographic Details
Main Authors: Proetel, Ulrike (Author) , Müller, Martin Christian (Author) , Hanfstein, Benjamin (Author) , Kalmanti, Lida (Author) , Schreiber, Annette (Author) , Hofmann, Wolf-Karsten (Author) , Hehlmann, Rüdiger (Author) , Saußele, Susanne (Author)
Format: Article (Journal)
Language:English
Published: 2014
In: Annals of hematology
Year: 2014, Volume: 93, Issue: 7, Pages: 1167-1176
ISSN:1432-0584
Online Access:Verlag, Volltext: http://link.springer.com/article/10.1007/s00277-014-2041-0/fulltext.html
Get full text
Author Notes:Ulrike Proetel, Nadine Pletsch, Michael Lauseker, Martin C. Müller, Benjamin Hanfstein, Stefan W. Krause, Lida Kalmanti, Annette Schreiber, Dominik Heim, Gabriela M. Baerlocher, Wolf-Karsten Hofmann, Elisabeth Lange, Hermann Einsele, Martin Wernli, Stephan Kremers, Rudolf Schlag, Lothar Müller, Mathias Hänel, Hartmut Link, Bernd Hertenstein, Markus Pfirrmann, Andreas Hochhaus, Joerg Hasford, Rüdiger Hehlmann, Susanne Saußele
Description
Item Description:Gesehen am: 16.12.2015
Physical Description:Online Resource
ISSN:1432-0584